Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2006
06/27/2006US7067301 Comprises nucleotide sequences coding prothrombin enzyme for diagnosis, treatment and prevention of nervous system, liver, blood and cancer disorders; wound healing agents
06/27/2006US7067300 Comprises nucleotide sequences coding 1,3-propanediol oxidoreductase (DHAT) for conversion of 3-hydroxypropionaldehyde to 1,3 propanediol
06/27/2006US7067298 Compositions and methods of using a synthetic Dnase I
06/27/2006US7067297 Mannosyltransferase polypeptides and polynucleotides encoding them and methods for making and using them
06/27/2006US7067296 Enzymatic polypeptide for use in the treatment of pain, inflammation, arthritis, cancer and alzheimer's disease
06/27/2006US7067295 Glucose dehydrogenase
06/27/2006US7067288 Nucleotide sequences which code for the mdhA gene
06/27/2006US7067287 mixing a nucleic acid-containing material with an accelerator, which binds the nucleic acids to a solid phase; isolating, washing the solid phase containing bound nucleic acids with a a chaotropic substance and then washing with a solution containing alcohol and acetate, eluting the nucleic acids
06/27/2006US7067286 Cystobacterineae host cells containing heterologous PKS genes for the synthesis of polykedtides
06/27/2006US7067285 Desaturase genes and uses thereof
06/27/2006US7067284 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
06/27/2006US7067282 Compositions and methods using the yeast YLR110C promoter
06/27/2006US7067281 Mammalian IAP gene family, primers, probes and detection methods
06/27/2006US7067280 Human cartilage glycoprotein
06/27/2006US7067278 capable of hybridizing and which encodes a pigment protein capable of emitting fluorescence upon irradiation; tissue marker, fluorescent marker or general dyestuff
06/27/2006US7067277 Chimeric G proteins and uses thereof
06/27/2006US7067274 Compositions and methods for the screening pro-apoptotic compounds
06/27/2006US7067271 screening for compounds that inhibit Amyloid-beta production by contacting a segment of a beta -secretase enzyme protein lacking a transmembrane region; amyloid precursor proteins
06/27/2006US7067265 Transgenic cells coding membrane protein which controls intracellular hydrogen ion concentration for identifying modulators for treatment of diabetes
06/27/2006US7067262 Determination binding of gabapentin to cells
06/27/2006US7067260 Detecting modulators of receptor binding activity; obtain sample containing receptor protein, incubate with modulator, monitor and evaluate protein binding
06/27/2006US7067256 Ribozyme mediated inactivation of the androgen receptor
06/27/2006US7067255 Hereditary hemochromatosis gene
06/27/2006US7067252 Detecting preferential gene products in sample; obtain sample, generate antibodies to gene product, obtain cell, transform with vector containing preferential gene product, incubate with antibody, detect signal from bound antibody
06/27/2006US7067251 Methods of directly selecting cells expressing inserts of interest
06/27/2006US7067249 with stably expressed short hairpin rnas which degrade hbv pregenomic rna and mRNA; for treatment of cancer, hormonal therapy, immunotherapy, and radiation therapy
06/27/2006US7067248 Screening method for orthopoxvirus antivirals
06/27/2006US7067245 selecting a host or replicator virus by by growing a population of viruses in a high selection pressure strain of bacteria where activity of interest confers a growth advantage; expanding the virus population, cycling the virus population through the process again
06/27/2006US7067133 Expression vector encoding a fusion protein with segments of a region which binds to an epitope or fragment and fragment or whole proteins that can cross the blood brain barrier
06/27/2006US7067131 Methods for using anti-MUC18 antibodies
06/27/2006US7067130 Genetic engineering; polypeptide; cancer diagnosis
06/27/2006US7067128 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
06/27/2006US7067127 Amino and nucleotide sequences; isolated, hybrid nucleic acid; purification of enzyme
06/27/2006US7067126 Synthase enzymes having chemokine, angiogenic or angiostsatic activity, used for medical diagnosis and prognosis
06/27/2006US7067125 Lantibiotic polypeptides; useful as antimicrobials in antibiotic pharmaceutical preparation and as antimicrobial or antiseptic dentifrice
06/27/2006US7067121 Grafting heart tissue; closure of heart defect
06/27/2006US7067120 Cytokine gene modified antigen-presenting cell/tumor cell conjugate, its preparation and use
06/27/2006US7067118 Methods of using mutant flt3-ligand polypeptides to induce cellular expansion
06/27/2006US7066982 Contaminant removal by ferns via foliar-application and excised/ground fronds
06/27/2006US7065920 Contaminant removal by additional ferns
06/27/2006CA2426283C Method for direct rescue and amplification of integrated viruses from cellular dna of tissues
06/27/2006CA2283740C Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
06/27/2006CA2263729C Process for producing mammals with defined genetic properties
06/27/2006CA2237224C Synthetic hpv11 virus-like particles
06/27/2006CA2124034C Gene coding for a protein regulating aureobasidin sensitivity
06/24/2006CA2494575A1 Compositions and methods for the treatment of osteoporosis
06/22/2006WO2006066268A2 Synthetic transcription regulators
06/22/2006WO2006066247A2 Methods and compositions for extending telomere length and increasing cell lifespan
06/22/2006WO2006066224A2 Virulence targeted antibiotics
06/22/2006WO2006066203A2 Small interfering rna (sirna) molecules for modulating superoxide dismutase (sod)
06/22/2006WO2006066193A2 Root active promoters and uses thereof
06/22/2006WO2006066168A2 Drought responsive promoters and uses thereof
06/22/2006WO2006066158A2 Rnai modulation of mll-af4 and uses thereof
06/22/2006WO2006066134A2 Nucleotide sequences and polypeptides encoded thereby useful for enhancing plant drought tolerance
06/22/2006WO2006066089A1 Humanized amyloid beta antibodies for use in improving cognition
06/22/2006WO2006066066A2 Chimeric vectors
06/22/2006WO2006065975A2 Methods of treating ankylosing spondylitis using anti-tnf antibodies and peptides of human tumor necrosis factor
06/22/2006WO2006065933A2 Oxygen-controlled environment for cell- and tissue culture
06/22/2006WO2006065851A1 Biopolymer including prolamin and methods of making it
06/22/2006WO2006065821A2 Improved dna immunization with recombinase/transposase
06/22/2006WO2006065751A2 Cpg oligonucleotide prodrugs, compositions thereof and associated therapeutic methods
06/22/2006WO2006065582A2 Muteins of fibroblast growth factor 21
06/22/2006WO2006065552A2 Modulating plant nitrogen levels
06/22/2006WO2006065103A1 Recombiant vector containing mj1 gene and method of site-specific integration using the same
06/22/2006WO2006065095A1 Novel promoter nucleic acid derived from corynebacterium genus bacteria, expression cassette comprising the promoter and vector comprising the cassette, host cell comprising the vector and method for expressing a gene using the cell
06/22/2006WO2006065076A1 5'-xmp aminase mutant
06/22/2006WO2006064964A1 Method of identifying gene with variable expression
06/22/2006WO2006064864A1 Method of assessing cancerous conditions and reagent for detecting gene product to be used in the method
06/22/2006WO2006064847A1 Enhancer of nonviral origin to be added to vector
06/22/2006WO2006064813A1 Nucleic acid construct and method of transferring mutation into target region by using the same
06/22/2006WO2006064746A1 Method of breeding cells having improved tolerance to short-chain fatty acids
06/22/2006WO2006064745A1 Method of identifying nucleotide polymorphisms
06/22/2006WO2006064739A1 Method of treating biological sample for performing nucleic acid amplification
06/22/2006WO2006064737A1 Method of detecting gene methylation and method of examining neoplasm by detecting methylation
06/22/2006WO2006064721A1 Active form of subtilisin at low temperature
06/22/2006WO2006064640A1 Method of selectively disposing ferritin
06/22/2006WO2006064639A1 Titanium-binding ferritin and method of arraying inorganic particle
06/22/2006WO2006064591A1 Substrate and method of quantifying target substance
06/22/2006WO2006064519A2 Dnazymes for inhibition of japanese encephalitis virus replication
06/22/2006WO2006064197A2 Transgenic animals for assessing drug metabolism and toxicity
06/22/2006WO2006064007A1 Transgenic animal models for neurodevelopmental disorders
06/22/2006WO2006063963A1 Method to increase plant biomass in stress conditions
06/22/2006WO2006063862A1 Transformed plant expressing a dextransucrase and synthesizing a modified starch
06/22/2006WO2006063856A1 Post-translational modification of proteins in cell-free expression systems
06/22/2006WO2006063800A1 Cloning of honey bee allergen
06/22/2006WO2006063786A1 Method for improved selection of rnai transfectants
06/22/2006WO2006063752A1 Improved mevalonate kinase
06/22/2006WO2006063594A1 Alkaline bacillus amylase
06/22/2006WO2006063533A1 Reconstitution of 5-enolpyruvylshikimate-3-phosphate synthase activity by fragment complementation
06/22/2006WO2006063518A1 Multifunctional polypeptides
06/22/2006WO2006063486A1 A fibrinolysin of agkistrodon acutus venom and its usage
06/22/2006WO2006063462A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling
06/22/2006WO2006063445A1 Recombinant foot and mouth disease vaccine
06/22/2006WO2006063425A1 Expression vectors for treating bacterial infections
06/22/2006WO2006063397A1 Determinants of sensitivity to chemotherapeutic agents
06/22/2006WO2006042158A3 Methods and compositions for improving recombinant protein production
06/22/2006WO2006041917A3 An insecticidal plant cyclotide with activity against homopteran insects
06/22/2006WO2006039656A9 Modified small interfering rna molecules and methods of use
06/22/2006WO2006034832A3 Use of igfbp-2 in senescence diseases and for the maintenance of organ functions
06/22/2006WO2006029005A3 Promoter substitution for immunoglobulin therapy